Court Opinion

ID: 859254
Source: CourtListenerOpinion
Date Created: 2013-04-26 19:51:56.252813+00
Date Added: 2024-06-11T11:15:58.816419
License: Public Domain

STATE OF WEST VIRGINIA

                          SUPREME COURT OF APPEALS                                FILED
                                                                                 April 23, 2013

                                                                            RORY L. PERRY II, CLERK

WILLIAM MICHAEL REESE,                                                    SUPREME COURT OF APPEALS

                                                                              OF WEST VIRGINIA
Claimant Below, Petitioner

vs.)   No. 11-1542	 (BOR Appeal No. 2045795)
                   (Claim No. 2009086277)

WEST VIRGINIA DIVISION OF
ENVIRONMENTAL PROTECTION,
Employer Below, Respondent

                             MEMORANDUM DECISION
       Petitioner William Michael Reese, by Patrick Maroney, his attorney, appeals the decision
of the West Virginia Workers’ Compensation Board of Review. The West Virginia Division of
Environmental Protection, by H. Toney Stroud, its attorney, filed a timely response.

        This appeal arises from the Board of Review’s Final Order dated October 13, 2011, in
which the Board affirmed a March 10, 2011, Order of the Workers’ Compensation Office of
Judges. In its Order, the Office of Judges affirmed the claims administrator’s June 18, 2010,
decision denying Mr. Reese’s request for authorization of Lidoderm patches. The Court has
carefully reviewed the records, written arguments, and appendices contained in the briefs, and
the case is mature for consideration.

       This Court has considered the parties’ briefs and the record on appeal. The facts and legal
arguments are adequately presented, and the decisional process would not be significantly aided
by oral argument. Upon consideration of the standard of review, the briefs, and the record
presented, the Court finds no substantial question of law and no prejudicial error. For these
reasons, a memorandum decision is appropriate under Rule 21 of the Rules of Appellate
Procedure.

        Mr. Reese sustained multiple injuries on April 1, 2009, when he slipped and fell at work.
Dr. Ranson requested authorization for the use of Lidoderm patches, and stated in an April 7,
2010, treatment note that he was prescribing the patches because Mr. Reese had had success with
them in the past. On April 30, 2010, Dr. Mukkamala reviewed Mr. Reese’s medical record and
recommended that the request for authorization of Lidoderm patches be denied. He noted that the
compensable conditions in the claim are: lumbosacral sprain; sprain of back, unspecified;
                                                1
contusion of wrist; contusion of knees; sprain of neck; lumbar sprain; and thoracic sprain. Dr.
Mukkamala then found that Lidoderm patches are only approved by the FDA for the treatment of
post-herpatic neuralgia, and that therefore the use of Lidoderm in this case would be considered
an off-label use. On June 11, 2010, the StreetSelect Grievance Board recommended denying the
request for authorization of Lidoderm patches. It found that the record does not indicate what
condition the patches are being prescribed for, but found that Mr. Reese is one year post-injury
and eight months post-maximum medical improvement and therefore is outside the acute care
period for the use of an off-label medication. It further found that the record indicates that Mr.
Reese has had a long-term prescription for Lidoderm, but that there is no evidence showing
payment for the medication under the claim.

        In its Order affirming the June 18, 2010, claims administrator’s decision, the Office of
Judges held that the evidence of record failed to show that the use of Lidoderm is medically
related and reasonably required for the treatment of the April 1, 2009, injury. Mr. Reese disputes
this finding and asserts that the evidence of record demonstrates that the use of Lidoderm is
medically related and reasonably required for the treatment of the April 1, 2009, injury.

        The Office of Judges found that Dr. Ranson failed to explain how his request for
authorization of Lidoderm patches is related to the April 1, 2009, injury. The Office of Judges
further found that in light of the lack of support for authorization for Lidoderm patches contained
in the medical record, the April 30, 2010, findings of Dr. Mukkamala and the June 11, 2010,
findings of the StreetSelect Grievance Board are persuasive. The Board of Review reached the
same reasoned conclusions in its decision of October 13, 2011. We agree with the reasoning and
conclusions of the Board of Review.

        For the foregoing reasons, we find that the decision of the Board of Review is not in clear
violation of any constitutional or statutory provision, nor is it clearly the result of erroneous
conclusions of law, nor is it based upon a material misstatement or mischaracterization of the
evidentiary record. Therefore, the decision of the Board of Review is affirmed.

                                                                                        Affirmed.

ISSUED:     April 23, 2013

CONCURRED IN BY:
Chief Justice Brent D. Benjamin
Justice Robin J. Davis
Justice Margaret L. Workman
Justice Allen H. Loughry II

DISSENTING:
Justice Menis E. Ketchum
                                                2